IMC Chicago’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Buy
52,000
+7,600
+17% +$370K ﹤0.01% 2684
2026
Q1
$1.9M Buy
44,400
+100
+0.2% +$4.3K ﹤0.01% 2628
2025
Q4
$1.94M Buy
44,300
+14,900
+51% +$616K ﹤0.01% 2462
2025
Q3
$1.21M Buy
29,400
+5,000
+20% +$201K ﹤0.01% 2574
2025
Q2
$1.08M Buy
24,400
+11,900
+95% +$476K ﹤0.01% 2424
2025
Q1
$462K Buy
+12,500
New +$445K ﹤0.01% 2711

Other funds holding EXEL

IMC Chicago's EXEL Position: Q2 2026 in Review

IMC Chicago sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 9,170 shares — an estimated $446K sold.

IMC Chicago first reported a position in EXEL in Q4 2023 and held it in 2 quarters. The position peaked at $393K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • IMC Chicago reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 9,170 Exelixis shares in Q2 2026, an estimated $446K.
  • IMC Chicago first reported a position in Exelixis in Q4 2023 and held it in 2 quarters.
  • IMC Chicago's Exelixis position peaked at $393K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.